|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/00 | |
| A61K 31/496 | |||
| A61K 31/55 | |||
| A61P 9/04 | |||
| A61K 45/06 |
| (11) | Number of the document | 3313444 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16738288.6 |
| Date of filing the European patent application | 2016-06-24 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/039198 |
| Date | 2016-06-24 |
| (87) | Number | WO 2016/210240 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 201562185306 P | 2015-06-26 | US |
| (72) |
SCOTT, Robert, Andrew Donald, US
WASSERMAN, Scott, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | COMBINATION THERAPY OF CARDIAC MYOSIN ACTIVATOR AND SINUS NODE IF CURRENT INHIBITOR |
| COMBINATION THERAPY OF CARDIAC MYOSIN ACTIVATOR AND SINUS NODE IF CURRENT INHIBITOR |